冠状动脉慢性完全闭塞血运重建与否与心源性死亡及猝死风险
该长期队列研究纳入1162例尝试CTO-PCI的患者,其中837例血运重建、325例未血运重建。中位随访6年(最长12年)显示,未血运重建者心源性死亡和SCD/SVAs风险显著更高,且风险主要由梗死相关动脉CTO未血运重建亚组驱动。
要点
- CTO未血运重建者心源性死亡风险是血运重建者的2倍以上
- CTO未血运重建者SCD/SVAs风险是血运重建者的3倍
- 梗死相关动脉CTO未血运重建者不良事件风险最高
核心结论
- 长期随访中,CTO未行PCI血运重建者较血运重建者预后更差,心源性死亡风险超过2倍、SCD/SVAs风险达3倍。
- 梗死相关动脉CTO未血运重建的患者不良事件发生率最高。
研究设计与样本
- 来自1357例CTO-PCI患者队列,纳入1162例尝试CTO-PCI者,分为血运重建组837例和未血运重建组325例。
- 长期分析,随访最长12年,中位6年。
主要发现
- CTO未血运重建组 vs 血运重建组心源性死亡率为13%(43/325)vs 6%(48/837),p<0.001。
- CTO未血运重建组 vs 血运重建组SCD/SVAs累积发生率为7.5%(24/325)vs 2.5%(20/837),p<0.001。
- 梗死相关动脉CTO未血运重建 vs 血运重建组心源性死亡率为18% vs 7%,p<0.001;SCD/SVAs为14% vs 5%,p=0.001。
- 多变量Cox回归分析中,CTO未血运重建仍是总体人群和梗死相关动脉CTO患者中心源性死亡和SCD/SVAs较高风险的独立预测因素之一。
临床怎么用
- 对CTO患者应评估血运重建必要性,尤其梗死相关动脉CTO未血运重建者需加强风险监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study is to evaluate the long-term risk of cardiac death and sudden cardiac death (SCD) and/or sustained ventricular arrhythmias (SVAs) in patients with coronary chronic total occlusions (CTO) revascularised versus those with CTO not revascularised by percutaneous coronary intervention (PCI). METHODS: From a cohort of 1357 CTO-PCI patients, 1162 patients who underwent CTO PCI attempt were included in this long-term analysis: 837 patients were revascularised by PCI (CTO-R group) and 325 were not revascularised (CTO-NR group). Primary adverse endpoint was the incidence of cardiac death; secondary endpoint was the cumulative incidence of SCD/SVAs. RESULTS: Up to 12-year follow-up (median 6 year), compared with CTO-R patients, those with CTO-NR had significantly higher rate of cardiac death (13%[43/325]vs6%[48/837]; p<0.001) and SCD/SVAs (7.5%[24/325]vs2.5%[20/837]; p<0.001). The risk of cardiac death and SCD/SVAs was mainly driven by the subgroup of infarct-related artery (IRA) CTO patients and was significantly higher only in IRA CTO-NR patients (18%vs7%, p<0.001, 14%vs5%, p=0.001; IRA CTO-NR vs IRA CTO-R, respectively). At multivariable Cox hazards regression analysis, CTO-NR remains one of the strongest independent predictors of higher risk of cardiac death and of SCD/SVAs in the overall population and in IRA CTO patients. CONCLUSIONS: At long-term follow-up, patients with CTO not revascularised by PCI had worse outcomes compared with those with CTO revascularised, with >2-fold risk of cardiac death and threefold risk of SCD/SVAs. The presence of an infarct-related artery (IRA CTO) not revascularised identified the category of patients with the highest rate of adverse events .
引用
- Godino C, Giannattasio A, Scotti A, et al. Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion. Heart. 2019. PMID: 30792237. doi:10.1136/heartjnl-2018-314076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。